Related Experiment Video
Updated: Jun 4, 2025
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Carbidopa and ZnCarbidopa Induce Reductive Stress in MDA-MB-231 Cells
Agustin B Actis Dato1, Luciana G Naso1, Valeria R Martínez2
1Centro de Química Inorgánica (CEQUINOR-CONICET-UNLP- Asoc CICPBA)-, Departamento de Química-Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Boulevard 120 entre 60 y 64, C.C.962- (B1900AVV), 1900, La Plata, Argentina.
The novel zinc complex of carbidopa (ZnCarbi) shows potent anticancer and antimetastatic effects against aggressive breast cancer cells by inducing reductive stress and mitochondrial damage. ZnCarbi selectively targets cancer cells, sparing normal cells, and offers enhanced efficacy over carbidopa alone.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Redox imbalance, involving reactive oxygen species (ROS), is crucial for metal complex anticancer activity.
- Carbidopa inhibits MDA-MB-231 cells via reductive stress induction.
- Developing targeted cancer therapeutics remains a significant challenge.
Purpose of the Study:
- To design and evaluate a zinc-carbidopa metal complex (ZnCarbi) for enhanced anticancer and antimetastatic properties.
- To investigate the mechanism of action of ZnCarbi, focusing on redox modulation and cellular effects.
- To assess the selectivity of ZnCarbi against cancer cells versus normal cells.
Main Methods:
- Synthesis and characterization of the ZnCarbi metal complex.
- Cytotoxicity assays on MDA-MB-231, HEK293, A549, LM3, and HCT116 cell lines.
- Measurement of ROS levels, GSH/GSSG ratio, and mitochondrial function.
- Cell migration and invasion assays to evaluate antimetastatic potential.
- Bovine serum albumin (BSA) interaction studies.
Main Results:
- ZnCarbi exhibited significantly increased cytotoxicity against MDA-MB-231 cells compared to carbidopa.
- ZnCarbi demonstrated selective toxicity towards cancer cells, with no adverse effects on normal HEK293 cells or other tested cancer lines.
- Both carbidopa and ZnCarbi induced reductive stress, decreased ROS, elevated the GSH/GSSG ratio, and protected against H2O2-induced cell death.
- Mitochondrial damage and inhibition of cell migration/invasion were observed, indicating antimetastatic activity.
- BSA interaction studies suggested moderate binding via hydrophobic association.
Conclusions:
- ZnCarbi possesses enhanced anticancer and antimetastatic properties compared to carbidopa alone.
- The mechanism involves redox modulation, induction of reductive stress, and mitochondrial dysfunction.
- ZnCarbi shows promising selectivity for cancer cells, suggesting potential as a targeted therapeutic agent.
